FIELD: medicine.
SUBSTANCE: method involves determining HLA-DR+ lymphocyte and IgM immunoglobulin M. Leukocyte migration index is calculated. The values being found within the physiologic norm boundaries after having given treatment, remittent clinical course of disseminated sclerosis is to be predicted. No dynamic changes in HLA-DR+ lymphocyte content, reduced leukocyte migration index and increased IgM level being detected, progressive recurrent clinical course of disseminated sclerosis is to be predicted.
EFFECT: high accuracy of prognosis.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN GLUCOCORTICOIDS TREATED MULTIPLE SCLEROSIS | 2011 |
|
RU2438133C1 |
| METHOD FOR PREDICTION OF DEVELOPING MULTIPLE SCLEROSIS TAKING INTO ACCOUNT IMMUNE-METABOLIC VALUES | 2013 |
|
RU2528879C1 |
| METHOD FOR PREDICTION OF STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT VALUES OF IMMUNOLOGICAL STATUS | 2013 |
|
RU2528882C1 |
| METHOD OF PREDICTING EXACERBATIONS OF REMITTING MULTIPLE SCLEROSIS | 2011 |
|
RU2468370C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF MULTIPLE SCLEROSIS | 2014 |
|
RU2585120C2 |
| TREATMENT OF REMITTENT DISSEMINATED SCLEROSIS | 2005 |
|
RU2278687C1 |
| METHOD OF TREATING MULTIPLE SCLEROSIS IN CHILDREN | 2015 |
|
RU2596792C1 |
| METHOD FOR PROGNOSTICATING SEVERITY OF RUSSIAN TICK-BORNE ENCEPHALITIS | 0 |
|
SU1827633A1 |
| METHOD OF PREDICTING STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT INDICATORS OF IMMUNOLOGICAL STATUS | 2023 |
|
RU2811481C1 |
| METHOD OF THERAPY OF REMITTENT MULTIPLE SCLEROSIS | 2012 |
|
RU2523058C2 |
